武田制药

最新新闻

• 评级变动
  TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Maintains Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/1/30
• Společnosti Sceye a SoftBank Corp. Dokončily V Japonsku Demonstraci Stratosférického Připojení a Posunuly Se Tak Směrem Ke Komercializaci Systému HAPS
  PR Newswire · 2026/9/2
• 评级变动
  TR | OpenAI - 4o Initiates Takeda Pharmaceutical(TAK.US) With Hold Rating, Announces Target Price $15.5
  \u5e02\u573a\u8d44\u8baf · 2025/8/11
• 评级变动
  BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Raises Target Price to $37.37
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• [New Launch] Kai Tak Bay to Offer 100 Units via Price List on Saturday, with Net Selling Prices Starting at HK$5.6 Million
  AASTOCKS · 2026/9/2
• 评级变动
  TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Raises Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/3/31
• 评级变动
  TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Maintains Target Price $21
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 公司公告
  HCK: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO' DIONG TAK CHONG @ TIONG TAK CHONG
  Bursa Malaysia · 2026/6/29
• 公司公告
  OCEAN STAR TECH: PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING (THE "AGM")TO BE HELD AT 10:30 A.M. ON MONDAY, 28 SEPTEMBER 2026 AT ROOM 1606D&E, 16/F., KAI TAK COMMERCIALBUILDING, 317-319 DES VOEUX ROAD CENTRAL, SHEUNG WAN, HONG KONG (OR ANY ADJOURNMENT THEREOF)
  HKEX · 2026/9/4
• 公司公告
  World: Narumiya International accelerates its expansion in the Hong Kong market, with its kids' brand "petit main" opening consecutively at Sogo Causeway Bay and Kai Tak stores.
  JPX · 2026/5/25
• [New Launch] LOHAS Park’s Kai Tak Bay series has sold over 1,150 units, generating proceeds exceeding HK$10 billion.
  AASTOCKS · 2026/9/15
• BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Maintains Target Price $44.21
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 公司公告
  Takeda Pharmaceutical: U.S. FDA Accepts NDA and Grants Priority Review for Takeda's Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepy Type 1
  JPX · 2026/2/10
• 评级变动
  TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Announces Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2025/5/21
• 评级变动
  BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Raises Target Price to $37.47
  \u5e02\u573a\u8d44\u8baf · 2025/3/10
• 评级变动
  BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Announces Target Price $42.65
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 公司公告
  KING INTL INV: Form of proxy for the Annual General Meeting to be held at 12:00 p.m., Room 3302, 33/F, West Tower, Shun Tak Centre, 200 Connaught Road Central, HongKong on Friday, 4 September 2026.
  HKEX · 2026/7/31
• 评级变动
  TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Raises Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2025/9/9
• 评级变动
  BofA Securities Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• [Hong Kong Property] A four-bedroom unit at The Crown Kai Tak was sold for HK$169 million, translating to a price of HK$79,073 per square foot, setting new records for both transaction price and unit price among standard layouts.
  AASTOCKS · 2026/9/21
• Roadshow (00062.HK) and Sun Hung Kai Properties (00016.HK) have jointly submitted a bid for the Kai Tak Smart Green Mass Transit System.
  AASTOCKS · 2026/8/17

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。